← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Trabectedina currently has availability issues reported in 2 European registers: Spain, Greece.
Shortage ATC L01CX01 · also listed as: TRABECTEDINA · TRABECTEDIN · data refreshed 14 September 2026
As of 14 September 2026, 2 of the 9 tracked registers list current availability issues for Trabectedina, covering 2 affected product presentations. The longest-running open report was filed in Greece on 2026-07-10 and has now been open for about 2 months. Where agencies state a cause, delivery delays lead with 1 of the 1 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. In the WHO ATC classification, Trabectedina is coded L01CX01 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage TRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 2026-07-28 | — | — | register ↗ |
| 🇬🇷 Greece | Limited availability TRABECTEDIN/TEVA PD.C.S.INF 0.25MG/VIAL BT X 1 VIAL | 2026-07-10 | 2026-08-17 | Καθυστέρηση παράδοσης Εναλλακτικά άλλο σκεύασμα της ίδιας δραστικής, μ | register ↗ |
Every individual register entry for Trabectedina in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | TRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFU | Shortage | 2026-07-28 | — | |
| 🇬🇷 GR | TRABECTEDIN/TEVA PD.C.S.INF 0.25MG/VIAL BT X 1 VIAL | Limited availability | 2026-07-10 | 2026-08-17 | Καθυστέρηση παράδοσης Εναλλακτικά άλλο σκεύασμα της ίδιας δρ |
Yes. As of 14 September 2026, availability issues are reported in: Spain, Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Directly from the official medicines-agency registers that list Trabectedina: AEMPS CIMA (Spain), EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Trabectedina — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/trabectedina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Trabectedina availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/trabectedina/">Trabectedina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>